• Explore /
  • Poster
  • / The efficacy of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) on bone oligometastatic hormone-sensitive prostate cancer: A post hoc analysis of ARCHES.

The efficacy of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) on bone oligometastatic hormone-sensitive prostate cancer: A post hoc analysis of ARCHES.

Abstract Video & Slides Poster

Authors

Andrew Armstrong

Andrew J. Armstrong

Duke Cancer Institute Center for Prostate & Urologic Cancers, Duke University, Durham, NC

Andrew J. Armstrong , Taro Iguchi , Arun Azad , Arnauld Villers , Boris Alekseev , Daniel P. Petrylak , Russell Zelig Szmulewitz , Antonio Alcaraz , Neal D. Shore , Jeffrey Holzbeierlein , Francisco Gomez-Veiga , Brad Rosbrook , Fabian Zohren , Gabriel P. Haas , Georgia Gourgioti , Nader N. El-Chaar , Arnulf Stenzl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT02677896

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 5071)

DOI

10.1200/JCO.2021.39.15_suppl.5071

Abstract #

5071

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Neal D. Shore

First Author: Arun Azad

First Author: Christian Gratzke

Poster

2020 Genitourinary Cancers Symposium

Veterans affairs (VA) prostate cancer treatment (Tx) sequencing (VAPCaTS): A real-world study.

Veterans affairs (VA) prostate cancer treatment (Tx) sequencing (VAPCaTS): A real-world study.

First Author: Stephen J. Freedland